Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Dilated scalp capillaries might be a sign of hair loss related to COVID-19.

Trichoscopy is a reliable method for diagnosing hair and scalp disorders quickly and non-invasively.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

The document focused on hair disorders, especially alopecia, and discussed treatments and impacts on quality of life.

Low-cost videomicroscopes might not be reliable for examining scalp disorders compared to standard methods.

Low-cost videomicroscopes may not be reliable for diagnosing scalp disorders, smartphones could be reasonable for teledermatology, and U.S. residency programs need more teledermatology training.

The document discusses various nail and hair disorders and their treatments.

Alopecia can be linked to autoimmune diseases and shows different hair loss patterns.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Trichoscopy is essential for early detection and monitoring of female-pattern hair loss.

Minoxidil and finasteride effectively treat hair loss.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

A systematic approach is crucial for managing hair loss in women.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.

COVID-19 doesn't make alopecia areata worse.

Dermoscopy is becoming essential for diagnosing skin conditions and is expected to be a standard tool for dermatologists.

Poor sleep may lead to hair loss, and hair loss may affect sleep.

Diffuse telogen alopecia is temporary hair loss treated by addressing the root cause and improving scalp health.

Using scalp stem cells can improve hair transplants.

Botulinum toxin treatment improves hair follicle width and length in androgenetic alopecia.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

A 4-year-old girl with hair loss was diagnosed with early-onset trichotillomania and improved with behavioral interventions.